{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:03:05Z","timestamp":1790470985544,"version":"4.1.0"},"reference-count":46,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2022,10,1]]},"abstract":"Importance<\/jats:title>Impaired cognitive function in schizophrenia is associated with poor functional outcomes, but the role of rare coding variants is unclear.<\/jats:p><\/jats:sec>Objective<\/jats:title>To determine whether ultrarare constrained variants (URCVs) are associated with cognition in patients with schizophrenia.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>Linear regression was used to perform a within-case genetic association study of URCVs and current cognition and premorbid cognitive ability. A multivariable linear regression analysis of the outcomes associated with URCVs, schizophrenia polygenic risk score, polygenic risk score for intelligence and schizophrenia associated copy number variants on cognitive ability was performed. Exome sequencing data from 802 participants with schizophrenia were assessed for current cognition using the Measurement and Treatment Research to Improve Cognition in Schizophrenia Consensus Cognitive Battery and for estimated premorbid IQ using the National Adult Reading Test. Individuals were recruited from clinical and voluntary mental health services in the UK. Those with a diagnosis of intellectual disability or a neurological disorder known to affect cognition were excluded. Data collection occurred between 2007 and 2015. Data were analyzed between April 2020 and March 2022.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Association between URCVs, current cognition, and current cognition adjusted for premorbid IQ.<\/jats:p><\/jats:sec>Results<\/jats:title>Of the 802 participants, 499 (62%) were men and 303 (38%) were women; mean (SD) age at interview was 43.36 (11.87) years. Ultrarare constrained variants (n\u2009=\u2009400) were associated with lower current cognition scores (\u03b2\u2009=\u2009\u22120.18; SE\u2009=\u20090.07; P<\/jats:italic>\u2009=\u2009.005). In the univariable analysis, premorbid IQ was associated with URCVs (\u03b2\u2009=\u2009\u22120.12; SE\u2009=\u20090.05; P<\/jats:italic>\u2009=\u2009.02) and partly attenuated the association with current cognition (\u03b2\u2009=\u2009\u22120.09; SE\u2009=\u20090.05; P<\/jats:italic>\u2009=\u2009.08). Multivariable analysis showed that measured genetic factors combined accounted for 6.2% of variance in current cognition, 10.3% of variance in premorbid IQ, and supported outcomes of URCVs associated with current cognition independent of premorbid IQ (\u03b2\u2009=\u2009\u22120.10; SE\u2009=\u20090.05; P<\/jats:italic>\u2009=\u2009.03).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>The findings of this study suggest that URCVs contribute to variance in cognitive function in schizophrenia, with partly independent associations before and after onset of the disorder. Although the estimated effect sizes were small, future studies may show that the effect sizes will be greater with better annotation of pathogenic variants. Genomic data may contribute to identifying those at particularly high risk of cognitive impairment in whom early remedial or preventive measures can be implemented.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamapsychiatry.2022.2289","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T16:01:01Z","timestamp":1660924861000},"page":"963","source":"Crossref","is-referenced-by-count":16,"title":["Ultrarare Coding Variants and Cognitive Function in Schizophrenia"],"prefix":"10.1001","volume":"79","author":[{"given":"Hugo D. J.","family":"Creeth","sequence":"first","affiliation":[{"name":"MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliott","family":"Rees","sequence":"additional","affiliation":[{"name":"MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie E.","family":"Legge","sequence":"additional","affiliation":[{"name":"MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte A.","family":"Dennison","sequence":"additional","affiliation":[{"name":"MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Holmans","sequence":"additional","affiliation":[{"name":"MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T. R.","family":"Walters","sequence":"additional","affiliation":[{"name":"MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"O\u2019Donovan","sequence":"additional","affiliation":[{"name":"MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Owen","sequence":"additional","affiliation":[{"name":"MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10039","key":"yoi220049r1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","article-title":"Schizophrenia.","volume":"388","author":"Owen","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"yoi220049r2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/wps.v18.2","article-title":"Nonsocial and social cognition in schizophrenia: current evidence and future directions.","volume":"18","author":"Green","year":"2019","journal-title":"World Psychiatry"},{"issue":"5","key":"yoi220049r3","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1176\/appi.ajp.2008.07081242","article-title":"Premorbid IQ in schizophrenia: a meta-analytic review.","volume":"165","author":"Woodberry","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"2","key":"yoi220049r4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1017\/S0033291710001042","article-title":"Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder.","volume":"41","author":"Lewandowski","year":"2011","journal-title":"Psychol Med"},{"issue":"7","key":"yoi220049r5","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1001\/archpsyc.1987.01800190080012","article-title":"Implications of normal brain development for the pathogenesis of schizophrenia.","volume":"44","author":"Weinberger","year":"1987","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"yoi220049r6","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/wps.v16.3","article-title":"Schizophrenia and the neurodevelopmental continuum: evidence from genomics.","volume":"16","author":"Owen","year":"2017","journal-title":"World Psychiatry"},{"issue":"6600","key":"yoi220049r7","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/bmj.295.6600.681","article-title":"Is schizophrenia a neurodevelopmental disorder?","volume":"295","author":"Murray","year":"1987","journal-title":"BMJ (Clin Res Ed)"},{"issue":"2","key":"yoi220049r8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1017\/S0033291714001512","article-title":"Do premorbid and post-onset cognitive functioning differ between schizophrenia and bipolar disorder? a systematic review and meta-analysis.","volume":"45","author":"Trotta","year":"2015","journal-title":"Psychol Med"},{"issue":"1","key":"yoi220049r9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1176\/appi.ajp.2013.12111438","article-title":"Neuropsychological decline in schizophrenia from the premorbid to the postonset period: evidence from a population-representative longitudinal study.","volume":"171","author":"Meier","year":"2014","journal-title":"Am J Psychiatry"},{"issue":"7906","key":"yoi220049r10","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41586-022-04434-5","article-title":"Mapping genomic loci implicates genes and synaptic biology in schizophrenia.","volume":"604","author":"Trubetskoy","year":"2022","journal-title":"Nature"},{"issue":"1","key":"yoi220049r11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ng.3725","article-title":"Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects.","volume":"49","author":"Marshall","year":"2017","journal-title":"Nat Genet"},{"issue":"2","key":"yoi220049r12","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1192\/bjp.bp.113.131052","article-title":"Analysis of copy number variations at 15 schizophrenia-associated loci.","volume":"204","author":"Rees","year":"2014","journal-title":"Br J Psychiatry"},{"issue":"2","key":"yoi220049r13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41593-019-0564-3","article-title":"Exome sequencing in schizophrenia-affected parent-offspring trios reveals risk conferred by protein-coding de novo mutations.","volume":"23","author":"Howrigan","year":"2020","journal-title":"Nat Neurosci"},{"issue":"7487","key":"yoi220049r14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature12929","article-title":"De novo mutations in schizophrenia implicate synaptic networks.","volume":"506","author":"Fromer","year":"2014","journal-title":"Nature"},{"issue":"8","key":"yoi220049r15","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/ng.3903","article-title":"The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability.","volume":"49","author":"Singh","year":"2017","journal-title":"Nat Genet"},{"issue":"11","key":"yoi220049r16","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1038\/nn.4402","article-title":"Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia.","volume":"19","author":"Genovese","year":"2016","journal-title":"Nat Neurosci"},{"issue":"7906","key":"yoi220049r17","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41586-022-04556-w","article-title":"Rare coding variants in ten genes confer substantial risk for schizophrenia.","volume":"604","author":"Singh","year":"2022","journal-title":"Nature"},{"issue":"4","key":"yoi220049r18","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/nn.4267","article-title":"Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders.","volume":"19","author":"Singh","year":"2016","journal-title":"Nat Neurosci"},{"issue":"2","key":"yoi220049r19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41593-019-0565-2","article-title":"De novo mutations identified by exome sequencing implicate rare missense variants in SLC6A1 in schizophrenia.","volume":"23","author":"Rees","year":"2020","journal-title":"Nat Neurosci"},{"issue":"9","key":"yoi220049r20","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1001\/jamapsychiatry.2016.1831","article-title":"Analysis of intellectual disability copy number variants for association with schizophrenia.","volume":"73","author":"Rees","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"yoi220049r22","doi-asserted-by":"publisher","first-page":"5353","DOI":"10.1038\/s41467-021-25532-4","article-title":"Schizophrenia, autism spectrum disorders and developmental disorders share specific disruptive coding mutations.","volume":"12","author":"Rees","year":"2021","journal-title":"Nat Commun"},{"issue":"7","key":"yoi220049r23","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s41588-018-0152-6","article-title":"Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence.","volume":"50","author":"Savage","year":"2018","journal-title":"Nat Genet"},{"issue":"2","key":"yoi220049r24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.biopsych.2016.08.014","article-title":"cognitive performance among carriers of pathogenic copy number variants: analysis of 152,000 UK Biobank subjects.","volume":"82","author":"Kendall","year":"2017","journal-title":"Biol Psychiatry"},{"issue":"7483","key":"yoi220049r25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nature12818","article-title":"CNVs conferring risk of autism or schizophrenia affect cognition in controls.","volume":"505","author":"Stefansson","year":"2014","journal-title":"Nature"},{"issue":"7903","key":"yoi220049r26","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/s41586-022-04549-9","article-title":"Reduced reproductive success is associated with selective constraint on human genes.","volume":"603","author":"Gardner","year":"2022","journal-title":"Nature"},{"issue":"10","key":"yoi220049r27","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1001\/jamapsychiatry.2021.1961","article-title":"Associations between schizophrenia polygenic liability, symptom dimensions, and cognitive ability in schizophrenia.","volume":"78","author":"Legge","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"yoi220049r28","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1017\/S0033291713000196","article-title":"Schizophrenia genetic variants are not associated with intelligence.","volume":"43","author":"van Scheltinga","year":"2013","journal-title":"Psychol Med"},{"issue":"4","key":"yoi220049r29","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1176\/appi.ajp.2019.19050527","article-title":"Distinct polygenic score profiles in schizophrenia subgroups with different trajectories of cognitive development.","volume":"177","author":"Dickinson","year":"2020","journal-title":"Am J Psychiatry"},{"issue":"2","key":"yoi220049r30","first-page":"336","article-title":"The relationship between polygenic risk scores and cognition in schizophrenia.","volume":"46","author":"Richards","year":"2020","journal-title":"Schizophr Bull"},{"issue":"2","key":"yoi220049r31","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/mp.2013.166","article-title":"Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the Cognitive Genomics consorTium (COGENT).","volume":"19","author":"Lencz","year":"2014","journal-title":"Mol Psychiatry"},{"issue":"1","key":"yoi220049r32","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41398-018-0124-8","article-title":"Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls.","volume":"8","author":"Shafee","year":"2018","journal-title":"Transl Psychiatry"},{"issue":"1","key":"yoi220049r33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.biopsych.2020.11.025","article-title":"Rare copy number variants are associated with poorer cognition in schizophrenia.","volume":"90","author":"Hubbard","year":"2021","journal-title":"Biol Psychiatry"},{"issue":"4","key":"yoi220049r34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1503\/jpn.170076","article-title":"Examining cognition across the bipolar\/schizophrenia diagnostic spectrum.","volume":"43","author":"Lynham","year":"2018","journal-title":"J Psychiatry Neurosci"},{"issue":"1","key":"yoi220049r35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2004.09.006","article-title":"The MATRICS initiative: developing a consensus cognitive battery for clinical trials.","volume":"72","author":"Green","year":"2004","journal-title":"Schizophr Res"},{"issue":"9","key":"yoi220049r37","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"issue":"9","key":"yoi220049r38","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1093\/bioinformatics\/btu848","article-title":"PRSice: Polygenic Risk Score software.","volume":"31","author":"Euesden","year":"2015","journal-title":"Bioinformatics"},{"issue":"10","key":"yoi220049r39","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1111\/jcpp.12295","article-title":"Research review: polygenic methods and their application to psychiatric traits.","volume":"55","author":"Wray","year":"2014","journal-title":"J Child Psychol Psychiatry"},{"issue":"3","key":"yoi220049r40","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.cell.2019.12.036","article-title":"Large-scale exome sequencing study implicates both developmental and functional changes in the neurobiology of autism.","volume":"180","author":"Satterstrom","year":"2020","journal-title":"Cell"},{"issue":"7809","key":"yoi220049r41","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans.","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"issue":"2","key":"yoi220049r43","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1176\/appi.ajp.2009.09040574","article-title":"Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study.","volume":"167","author":"Reichenberg","year":"2010","journal-title":"Am J Psychiatry"},{"issue":"8934","key":"yoi220049r44","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/S0140-6736(94)90569-X","article-title":"Child development risk factors for adult schizophrenia in the British 1946 birth cohort.","volume":"344","author":"Jones","year":"1994","journal-title":"Lancet"},{"issue":"3","key":"yoi220049r45","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1001\/jamapsychiatry.2017.4327","article-title":"Course of cognitive development from infancy to early adulthood in the psychosis spectrum.","volume":"75","author":"Mollon","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"yoi220049r46","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1017\/S0033291701003634","article-title":"The NART as an index of prior intellectual functioning: a retrospective validity study covering a 66-year interval.","volume":"31","author":"Crawford","year":"2001","journal-title":"Psychol Med"},{"key":"yoi220049r36","volume-title":"The National Adult Reading Test (NART)","author":"Nelson","year":"1991"},{"key":"yoi220049r21","doi-asserted-by":"crossref","unstructured":"The Schizophrenia Working Group of the Psychiatric Genomics Consortium. Mapping genomic loci prioritises genes and implicates synaptic biology in schizophrenia.? medRxiv. Preprint posted online September 13, 2020. doi:10.1101\/2020.09.12.20192922","DOI":"10.1101\/2020.09.12.20192922"},{"key":"yoi220049r42","doi-asserted-by":"crossref","unstructured":"Samocha? K, Kosmicki? J, Karczewski? K, . Regional missense constraint improves variant deleteriousness prediction.? bioRxiv. Preprint posted online June 12, 2017. doi:10.1101\/148353","DOI":"10.1101\/148353"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2795508\/jamapsychiatry_creeth_2022_oi_220049_1664208837.33965.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T15:01:41Z","timestamp":1664982101000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2795508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2022.2289","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,1]]}}}